Revisiting Human Cholesterol Synthesis and Absorption: The Reciprocity Paradigm and its Key Regulators
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Hypercholesterolemia is a major risk factor for cardiovascular disease. Cholesterol homeostasis in the body is governed by the interplay between absorption, synthesis, and excretion or conversion of cholesterol into bile acids. A reciprocal relationship between cholesterol synthesis and absorption is known to regulate circulating cholesterol in response to dietary or therapeutic interventions. However, the degree to which these factors affect synthesis and absorption and the extent to which one vector shifts in response to the other are not thoroughly understood. Also, huge inter‐individual variability exists in the manner in which the two systems act in response to any cholesterol‐lowering treatment. Various factors are known to account for this variability and in light of recent experimental advances new players such as gene–gene interactions, gene–environmental effects, and gut microbiome hold immense potential in offering an explanation to the complex traits of inter‐individual variability in human cholesterol metabolism. In this context, the objective of the present review is to provide an overview on cholesterol metabolism and discuss the role of potential factors such as genetics, epigenetics, epistasis, and gut microbiome, as well as other regulators in modulating cholesterol metabolism, especially emphasizing the reciprocal relationship between cholesterol synthesis and absorption. Furthermore, an evaluation of the implications of this push–pull mechanism on cholesterol‐lowering strategies is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708473 · Cited by 3,898 · cited 1×
“Evidence is accumulating that environmental factors are able to alter gene expression and change the phenotype through modification of the epigenome [94, 95].”
Personal genomes: The case of the missing heritability
Maher, B. (2008) · Nature · doi:10.1038/456018a · Cited by 1,737 · cited 1×
“Most of the SNP associated with complex diseases bear a small effect size and only contribute to a minuscule portion of the variability caused by their additive effects [205, 206].”
BackgroundKathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.75 · Cited by 1,386 · cited 1×
“Most of the novel variants in candidate loci that modulate plasma cholesterol levels identified through genome-wide association studies (GWAS) lack a functional explanation [69, 70].”
BackgroundDetecting gene–gene interactions that underlie human diseases
Cordell, H. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2579 · Cited by 1,350 · cited 1×
“However, its application is at its inception and is limited by the requirement of elaborate and complex series of analyses [209].”
BackgroundReciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158
Human genetic variation and its contribution to complex traits
Frazer, K. A., Murray, S. S., Schork, N. J., & Topol, E. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2554 · Cited by 1,073 · cited 1×
“Most of the SNP associated with complex diseases bear a small effect size and only contribute to a minuscule portion of the variability caused by their additive effects [205, 206].”
BackgroundEndocrine Disruptors: From Endocrine to Metabolic Disruption
Casals-Casas, C., & Desvergne, B. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142200 · Cited by 902
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
Sudhop, T., Lütjohann, D., Kodal, A., Igel, M., Tribble, D. L., Shah, S., Perevozskaya, I., & von Bergmann, K. (2002) · Circulation · doi:10.1161/01.cir.0000034044.95911.dc · Cited by 682
Al-Lahham, S. H., Peppelenbosch, M. P., Roelofsen, H., Vonk, R. J., & Venema, K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.07.007 · Cited by 614
Metabolism of Cholesterol and Bile Acids by the Gut Microbiota
Gérard, P. (2013) · Pathogens · doi:10.3390/pathogens3010014 · Cited by 580 · cited 2×
“Gut microbiota are known to metabolize cholesterol and bile acids, but their influence on cholesterol synthesis and absorption is an unexplored area [109].”
BackgroundmiR-33 links SREBP-2 induction to repression of sterol transporters
Marquart, T. J., Allen, R. M., Ory, D. S., & Baldán, Á. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005191107 · Cited by 562 · cited 1×
“Low cholesterol levels induce the increase in miR-33a together with SREBP2, whereas high sterol levels promote the opposite [72].”
BackgroundMechanisms Underlying the Cholesterol-Lowering Properties of Soluble Dietary Fibre Polysaccharides
Gunness, P., & Gidley, M. J. (2010) · Food & Function · doi:10.1039/c0fo00080a · Cited by 527 · cited 1×
“Another potential possibility by which dietary fibres could directly affect cholesterol synthesis is by lowering postprandial glucose levels, resulting in a decline in insulin levels and consequently suppressing hepatic cholesterol synthesis by inhibition of HMGCR [158].”
BackgroundIntestinal ABCA1 directly contributes to HDL biogenesis in vivo
Brunham, L. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27352 · Cited by 519 · cited 1×
“In addition, enterocytic cholesterol can be transferred to apolipoprotein A1 (apoA1) high density lipoprotein (HDL) particles via ATP-binding cassette transporter A1 (ABCA1) [136].”
BackgroundNibbling versus gorging: metabolic advantages of increased meal frequency
Jenkins, D. J. A., Wolever, T. M. S., Vuksan, V., Brighenti, F., Cunnane, S. C., Rao, A. V., Jenkins, A. L., Buckley, G., Patten, R., Singer, W., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910053211403 · Cited by 467
Central nervous system: cholesterol turnover, brain development and neurodegeneration
Dietschy, J. M. (2009) · bchm · doi:10.1515/bc.2009.035 · Cited by 394
Abumweis, S., Barake, R., & Jones, P. (2008) · Food & Nutrition Research · doi:10.3402/fnr.v52i0.1811 · Cited by 369 · cited 3×
“tion Plant sterols are naturally occurring sterols with very similar chemical structures to that of cholesterol [162].”
Self-citationWalker, A. K., Yang, F., Jiang, K., Ji, J.-Y., Watts, J. L., Purushotham, A., Boss, O., Hirsch, M. L., Ribich, S., Smith, J. J., et al. (2010) · Genes & Development · doi:10.1101/gad.1901210 · Cited by 357
Gill, S., Stevenson, J., Kristiana, I., & Brown, A. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.015 · Cited by 304
Liu, J., Sempos, C. T., Donahue, R. P., Dorn, J., Trevisan, M., & Grundy, S. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.032 · Cited by 277
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
Knutson, S. K., Chyla, B. J., Amann, J. M., Bhaskara, S., Huppert, S. S., & Hiebert, S. W. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.51 · Cited by 271 · cited 1×
“[79] in a HDAC3 knockout mouse model, liver cholesterol synthesis along with other cholesterogenic genes was markedly increased.”
BackgroundMartínez, I., Perdicaro, D. J., Brown, A. W., Hammons, S., Carden, T. J., Carr, T. P., Eskridge, K. M., & Walter, J. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03046-12 · Cited by 215 · cited 3×
“Alters absorption and synthesis [110, 111, 211]”
BackgroundMusa-Veloso, K., Poon, T. H., Elliot, J. A., & Chung, C. (2011) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.02.001 · Cited by 195
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Kaddurah-Daouk, R., Baillie, R. A., Zhu, H., Zeng, Z.-B., Wiest, M. M., Nguyen, U. T., Wojnoonski, K., Watkins, S. M., Trupp, M., & Krauss, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025482 · Cited by 193 · cited 2×
“A clinical trial conducted in 944 individuals taking simvastatin at 40 mg/day for 6 weeks used a targeted gas chromatography–mass spectrometry metabolomics platform to measure a panel of metabolites within cholesterol synthesis, dietary sterol absorption, and bile acid formation [112].”
BackgroundMethodDietary cholesterol: from physiology to cardiovascular risk
Lecerf, J.-M., & de Lorgeril, M. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511000237 · Cited by 182
The human microbiome and bile acid metabolism: Dysbiosis, dysmetabolism, disease and intervention
Jones, M. L., Martoni, C. J., Ganopolsky, J. G., Labbé, A., & Prakash, S. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.880420 · Cited by 150 · cited 3×
“Alters absorption and synthesis [110, 111, 211]”
BackgroundCell cholesterol homeostasis: Mediation by active cholesterol
Steck, T. L., & Lange, Y. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.08.007 · Cited by 139
Weng, W., Li, L., van Bennekum, A. M., Potter, S. H., Harrison, E. H., Blaner, W. S., Breslow, J. L., & Fisher, E. A. (1999) · Biochemistry · doi:10.1021/bi981679a · Cited by 135 · cited 1×
“This finding can explain why disruption of the CEL gene has a very modest effect on intestinal cholesterol absorption as demonstrated in mice [127, 128].”
Background
Cited by
General Health Benefits and Pharmacological Activities of Triticum aestivum L.
Moshawih, S., Abdullah Juperi, R. N. A., Paneerselvam, G. S., Ming, L. C., Liew, K. B., Goh, B. H., Al-Worafi, Y. M., Choo, C.-Y., Thuraisingam, S., Goh, H. P., et al. (2022) · Molecules · doi:10.3390/molecules27061948 · Cited by 345
Molecular Pathways Underlying Cholesterol Homeostasis
Afonso, M. S., Machado, R. M., Lavrador, M., Quintao, E. C. R., Moore, K., & Lottenberg, A. (2018) · Nutrients · doi:10.3390/nu10060760 · Cited by 138
The role of lipid biomarkers in major depression
Parekh, A., Smeeth, D., Milner, Y., & Thuret, S. (2017) · Healthcare · doi:10.3390/healthcare5010005 · Cited by 120
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
“Squalene undergoes cyclization and further conversion to lanosterol and eventually generates cholesterol (15).”
Metadata
- Authors
- Alphonse, P. A. S., & Jones, P. J. H.
- Venue
- Lipids
- Publisher
- Wiley
- Published
- 2015-11-30
- Volume
- 51
- Issue
- 5
- Pages
- 519-536
- ISSN
- 0024-4201 (ISSN-L)
- 1558-9307
- OpenAlex
- W2186765149
- Cited by
- 116
- References
- 29
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.